retatrutide obesity triple hormone receptor agonist Original Article: Triple–Hormone-Receptor for — A Phase 2 Trial https://t.co/jNL1GNnHPT #ADA23 Weight loss with retatrutide as

The best thing you can do is have a conversation with a healthcare provider

Your healthcare provider can help you understand the differences between the two and guide you in choosing the most suitable option for your weight loss journey

G.et al (2020)

These compounds stimulate intestinal cells to release GLP-1, helping regulate appetite, improve satiety, and support metabolic health

Its not a substitute for lifestyle changes

A large retrospective meta-analysis of prospectively adjudicated cardiovascular events has been recently published, including data from 40 double-blind, randomised-controlled phase III and IV studies encompassing about 17,500 patients (mean age 57 years) receiving vildagliptin 50 mg once and twice daily, or comparators [116]